Bhanu K. Sadasivan, PhD - McDermott Will & Emery


Bhanu K. Sadasivan, PhD, focuses her practice on patent litigation, with an emphasis in the life sciences industry. She has experience litigating patent cases concerning recombinant DNA technology, pharmaceutical formulation, computer hardware and software.

Show More


  • Representing Natera in litigation over patents covering methods of preparing DNA
  • Represented 23andMe in litigation over a patent covering a method of finding relative relationships
  • Represented Quidel in a patent litigation over lateral flow assay method
  • Represented Amgen in a patent litigation matter over novel antibody therapeutics for the treatment of high LDL-cholesterol (Amgen v. Sanofi, et al., (D. Delaware))

Show More


  • IAM Patent 1000 – The World’s Leading Patent Practitioners, 2022
  • LMG Life Sciences, Shortlisted for General Patent Litigator of the Year – California, 2021
  • Managing Intellectual Property, IP Stars, 2021 & 2022
  • LMG Life Sciences 2022 – Leading Life Sciences Lawyer
  • Super Lawyers 2013 to 2014, Rising Star, IP litigation
  • The Legal 500 US 2021 and 2022
  • Lawdragon, Top 500 Leading Litigators in America, 2022


  • Asian Law Alliance, board member and previous board president


University of California – Berkeley School of Law, JD
Yale University, PhD, Immunology
All India Institute of Medical Sciences, MS, Immunology, with honors
All India Institute of Medical Sciences, BSc, Human Biology, with honors


Show More